• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number MDT-TRANS VALVE
Device Problems Perivalvular Leak (1457); Malposition of Device (2616)
Patient Problems Intimal Dissection (1333); Atrial Fibrillation (1729); Stroke/CVA (1770); Non specific EKG/ECG Changes (1817); Insufficiency, Valvular (1926); Perforation of Vessels (2135); Rupture (2208); Cardiac Tamponade (2226); Blood Loss (2597)
Event Date 02/08/2020
Event Type  Injury  
Manufacturer Narrative
Citation: pineda am et al.Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis.Am heart j.2020 jun;224:105-112.Doi: 10.1016/j.Ahj.2020.02.003.Epub 2020 feb 8.Earliest date of publish used for date of event.Medtronic products referenced: corevalve (pma# p130021, pro code npt), evolut r (pma# p130021, pro code npt).Earliest approved product used for product code and pma#.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information from a literature article regarding an evaluation of the outcomes following transcatheter aortic valve replacement (tavr) in patients with bicuspid aortic valve stenosis compared to patients with trileaflet aortic valve stenosis.All data were retrospectively collected from a single center between april 2011 and november 2016.The study population included 567 patients (50 with bicuspid aortic valve stenosis, 517 with trileaflet aortic valve stenosis) and was predominantly male with a median age of 81 years and 88.4% were white.Of those, 333 patients were implanted with medtronic corevalve or evolut r self-expanding transcatheter valves.No serial numbers were provided.Among all patients treated with self-expanding transcatheter valves (corevalve or evolut r), 71 all-cause deaths occurred within two years after tavr.No further details were provided about the deaths.Based on the available information, medtronic product was not directly associated with the deaths.Among all patients in the study population, intra-operative adverse events included: valve malposition requiring intervention, ventricular perforation or tamponade, annular rupture, conversion to open-heart surgery, and aortic dissection.Based on the available information, medtronic product may have been associated with these adverse events.Among all patients treated with self-expanding transcatheter valves (corevalve or evolut r), post-operative in-hospital adverse events included: new permanent pacemaker implantation, ischemic stroke, unplanned cardiac or vascular surgery, new onset atrial fibrillation, mild to severe paravalvular regurgitation/leak, major vascular complications, and life-threatening or disabling bleeding.Based on the available information, medtronic product was associated with these adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC TRANSCATHETER VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key10605805
MDR Text Key209144431
Report Number2025587-2020-02965
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 09/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMDT-TRANS VALVE
Device Catalogue NumberMDT-TRANS VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/02/2020
Initial Date FDA Received09/30/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention; Disability;
Patient Age81 YR
-
-